Danaher Co. (NYSE:DHR) Shares Sold by West Oak Capital LLC

West Oak Capital LLC lessened its position in shares of Danaher Co. (NYSE:DHR) by 0.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,316 shares of the conglomerate’s stock after selling 95 shares during the quarter. West Oak Capital LLC’s holdings in Danaher were worth $2,115,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Spinnaker Trust grew its stake in Danaher by 1.2% during the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after acquiring an additional 50 shares in the last quarter. Fortis Capital Advisors LLC increased its stake in Danaher by 1.3% in the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock valued at $914,000 after buying an additional 50 shares during the period. Fayez Sarofim & Co lifted its position in Danaher by 0.6% in the 4th quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate’s stock worth $1,902,000 after buying an additional 50 shares in the last quarter. Coastal Bridge Advisors LLC boosted its stake in shares of Danaher by 4.8% during the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate’s stock valued at $252,000 after buying an additional 50 shares during the period. Finally, Perennial Investment Advisors LLC grew its holdings in shares of Danaher by 2.2% during the 4th quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate’s stock valued at $538,000 after acquiring an additional 51 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Barclays lifted their price objective on Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a research report on Tuesday, April 22nd. Guggenheim reaffirmed a “buy” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Jefferies Financial Group decreased their price target on Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research report on Tuesday, April 22nd. Finally, Bank of America cut their price objective on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $248.17.

Danaher Stock Up 1.0%

Shares of NYSE DHR opened at $204.62 on Thursday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $146.44 billion, a PE ratio of 38.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77. The firm’s 50-day moving average is $191.79 and its 200-day moving average is $211.67. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Equities analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher’s dividend payout ratio (DPR) is currently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.